Related Experiment Video
Updated: Aug 9, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Modulation of human papillomavirus type 16 mRNA in cervical invasive carcinoma patients by interferon-alpha therapy
R García-Milián1, M A Rios, M Amigó
1Departamento de Biologia Celular, Centro de Investigaciones Biologicas, Ciudad Habana, Cuba.
Abstract:
Mechanisms by which interferon produces papilloma regression remain largely unknown. We analyzed biopsies from three cervical invasive carcinoma patients treated with interferon-alpha (IFN-alpha) administered both topically and i.m. for 15 days. All specimens contained human papillomavirus (HPV-16) DNA as determined by polymerase chain reaction using specific HPV-16 E7 primers. Interestingly, in two patients. HPV-16 mRNA expression was reduced (44% and 67%, respectively) after IFN treatment. Upregulation of 2-5 A synthetase and PKR mRNA levels were indicative of the IFN effect. A larger study should be initiated to see whether IFN-alpha modulates the HPV-16 mRNA levels in tumor biopsies from cervical carcinoma patients.
Insights
Interferon-alpha (IFN-alpha) treatment reduced human papillomavirus (HPV-16) mRNA expression in cervical cancer patients. This suggests IFN-alpha may modulate HPV-16 levels, warranting further investigation.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- The mechanisms of interferon-induced papilloma regression are not well understood.
- Cervical cancer is often associated with human papillomavirus (HPV) infections.
Purpose of the Study:
- To investigate the effect of interferon-alpha (IFN-alpha) on human papillomavirus (HPV-16) mRNA expression in cervical cancer patients.
- To explore the potential role of IFN-alpha in modulating HPV-16 levels in tumor biopsies.
Main Methods:
- Analysis of tumor biopsies from three cervical invasive carcinoma patients treated with topical and intramuscular IFN-alpha for 15 days.
- Detection of HPV-16 DNA using polymerase chain reaction (PCR) with specific HPV-16 E7 primers.
- Quantification of HPV-16 mRNA expression and assessment of 2-5 A synthetase and PKR mRNA levels.
Main Results:
- All analyzed specimens tested positive for HPV-16 DNA.
- Two out of three patients showed a reduction in HPV-16 mRNA expression (44% and 67%) post-IFN-alpha treatment.
- Upregulation of 2-5 A synthetase and PKR mRNA levels indicated a biological response to IFN-alpha.
Conclusions:
- IFN-alpha treatment may modulate HPV-16 mRNA levels in cervical cancer patients.
- Further large-scale studies are recommended to confirm the impact of IFN-alpha on HPV-16 mRNA expression in tumor biopsies.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 12, 2014
10:00High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly